Hemophilia
Hemophilia: Recent Insights - May 26, 2015
CDC information: Do you have hemophilia and an inhibitor?
Pain Toolkit,
from the Hemophilia Foundation
from the Hemophilia FoundationThe current status of prophylactic replacement therapy in children and adults with haemophilia.
Ljung R et al. Br. J. Haematol. 2015 Mar 29.
Ljung R et al. Br. J. Haematol. 2015 Mar 29.
Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens.
Oldenburg J et al. Blood 2015 Mar 26. (13) 2038-2044
Oldenburg J et al. Blood 2015 Mar 26. (13) 2038-2044
FVIII inhibitors: pathogenesis and avoidance.
Astermark Jan et al. Blood 2015 Feb 23.
Astermark Jan et al. Blood 2015 Feb 23.
Rare bleeding disorders: diagnosis and treatment.
Palla Roberta et al. Blood 2015 Feb 23.
Palla Roberta et al. Blood 2015 Feb 23.
Haemophilia A: Pharmacoeconomic review of prophylaxis treatment versus on-demand.
Unim Brigid et al. ScientificWorldJournal 2015;2015:596164.
Unim Brigid et al. ScientificWorldJournal 2015;2015:596164.
Hemophilia A: Dental considerations and management.
Shastry Shilpa Padar et al. J Int Soc Prev Community Dent 2014 Dec (Suppl 3) S147-52
Shastry Shilpa Padar et al. J Int Soc Prev Community Dent 2014 Dec (Suppl 3) S147-52
Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors.
Ewing N et al. Haemophilia 2015 Jan 21.
Ewing N et al. Haemophilia 2015 Jan 21.
Individualizing prophylaxis in hemophilia: a review.
Petrini Pia et al. Expert Rev Hematol 2015 Jan 20. 1-10
Petrini Pia et al. Expert Rev Hematol 2015 Jan 20. 1-10
Hemophilia A: an ideal disease to correct in utero.
Porada Christopher D et al. Front Pharmacol 2014 276
Porada Christopher D et al. Front Pharmacol 2014 276
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies.
Baghaipour Mohammad Reza et al. Eur. J. Haematol. 2015 Feb 30-7
Baghaipour Mohammad Reza et al. Eur. J. Haematol. 2015 Feb 30-7
Genetic risk factors for inhibitors in haemophilia A.
Bardi Edit et al. Eur. J. Haematol. 2015 Feb 7-10
Bardi Edit et al. Eur. J. Haematol. 2015 Feb 7-10
Non-genetic risk factors and their influence on the management of patients in the clinic.
Álvarez Teresa et al. Eur. J. Haematol. 2015 Feb 2-6
Álvarez Teresa et al. Eur. J. Haematol. 2015 Feb 2-6
Gene therapy for hemophilia.
Rogers Geoffrey L et al. Front Biosci (Landmark Ed) 2015 556-603
Rogers Geoffrey L et al. Front Biosci (Landmark Ed) 2015 556-603
A new recombinant factor VIII: from genetics to clinical use.
Santagostino Elena et al. Drug Des Devel Ther 2014 2507-15
Santagostino Elena et al. Drug Des Devel Ther 2014 2507-15
Hemophilia: Recent Insights and Progress in Gene Therapy - December 4, 2014
Nature Outlook Special Hemophilia Supplement (November, 2014) Hopes are rising rapidly for people with the bleeding disorder haemophilia. The advent of longer-lasting blood-clotting factors is making treatment less onerous, and gene therapy offers a potential cure
(November, 2014) Hopes are rising rapidly for people with the bleeding disorder haemophilia. The advent of longer-lasting blood-clotting factors is making treatment less onerous, and gene therapy offers a potential cureHemophilia video: Rockstars and flying cars
Recent CDC articles:
Haemophilia Centre Accreditation Systems and Networks of Centres of Expertise for Rare Diseases in Europe and North America (off subscription)
Blood Transfusion 2014; 12 Suppl 3
The National Haemophilia program standards, evaluation and oversight systems in the United States of America.
Skinner MW, et al. Blood Transfus 2014; 12 (Suppl 3): s542-8.
Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database
Puetz J, et al. Haemophilia; 2014; Volume 20, Number 1, pp. 25-31
Identifying information needs among children and teens living with haemophilia
Simmons GM, et al. Haemophilia; 2014; Volume 20, Number 1, pp. 1-8
(off subscription)Blood Transfusion 2014; 12 Suppl 3
The National Haemophilia program standards, evaluation and oversight systems in the United States of America.
Skinner MW, et al. Blood Transfus 2014; 12 (Suppl 3): s542-8.
Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database
Puetz J, et al. Haemophilia; 2014; Volume 20, Number 1, pp. 25-31
Identifying information needs among children and teens living with haemophilia
Simmons GM, et al. Haemophilia; 2014; Volume 20, Number 1, pp. 1-8
World Hemophilia Day: April 17 - April 17, 2014
CDC information: Hemophilia is an inherited bleeding disorder in which the blood does not clot properly
CDC information: Many people with hemophilia will develop an inhibitor
CDC information: Hemophilia and maintaining a healthy weight
CDC information: The safety of blood products is important for people with hemophilia
[PDF 635.56 KB]
.png)
No hay comentarios:
Publicar un comentario